JP2023543924A5 - - Google Patents
Info
- Publication number
- JP2023543924A5 JP2023543924A5 JP2023520459A JP2023520459A JP2023543924A5 JP 2023543924 A5 JP2023543924 A5 JP 2023543924A5 JP 2023520459 A JP2023520459 A JP 2023520459A JP 2023520459 A JP2023520459 A JP 2023520459A JP 2023543924 A5 JP2023543924 A5 JP 2023543924A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- formula
- acceptable salt
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2015585.9A GB202015585D0 (en) | 2020-10-01 | 2020-10-01 | New compounds |
| GB2015585.9 | 2020-10-01 | ||
| PCT/GB2021/052535 WO2022069894A1 (en) | 2020-10-01 | 2021-09-30 | Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023543924A JP2023543924A (ja) | 2023-10-18 |
| JP2023543924A5 true JP2023543924A5 (https=) | 2024-10-04 |
| JP7793614B2 JP7793614B2 (ja) | 2026-01-05 |
Family
ID=73223766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520459A Active JP7793614B2 (ja) | 2020-10-01 | 2021-09-30 | チアジアゾロン誘導体と、それらの糖尿病および関連疾患の治療のためのａｍｐｋアゴニストとしての使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230382930A1 (https=) |
| EP (1) | EP4222147B1 (https=) |
| JP (1) | JP7793614B2 (https=) |
| KR (1) | KR20230079163A (https=) |
| CN (1) | CN116368141B (https=) |
| AU (1) | AU2021352146A1 (https=) |
| CA (1) | CA3193947A1 (https=) |
| ES (1) | ES3018732T3 (https=) |
| GB (1) | GB202015585D0 (https=) |
| HU (1) | HUE071685T2 (https=) |
| MX (1) | MX2023003825A (https=) |
| PL (1) | PL4222147T3 (https=) |
| WO (1) | WO2022069894A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11691954B2 (en) | 2019-10-18 | 2023-07-04 | Betagenon Ab | Formulations |
| GB202112529D0 (en) * | 2021-09-02 | 2021-10-20 | Betagenon Bio Ab | New compounds |
| EP4600642A1 (en) * | 2022-10-05 | 2025-08-13 | Sawai Pharmaceutical Co., Ltd. | Method for selecting additive capable of inhibiting nitrosation reaction, and preparation prevented from generation of nitroso compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5982281B2 (ja) * | 2009-07-08 | 2016-08-31 | バルティック バイオ アーベー | 医薬として有用な化合物 |
| WO2013108026A1 (en) * | 2012-01-17 | 2013-07-25 | Baltic Bio Ab | Thiadiazolone derivatives useful in the treatment of diabetes |
| AU2018448511B2 (en) * | 2018-11-05 | 2025-07-03 | Betagenon Ab | Methods of treating diabetes in severe insulin-resistant diabetic subjects |
-
2020
- 2020-10-01 GB GBGB2015585.9A patent/GB202015585D0/en not_active Ceased
-
2021
- 2021-09-30 CN CN202180067894.4A patent/CN116368141B/zh active Active
- 2021-09-30 HU HUE21816508A patent/HUE071685T2/hu unknown
- 2021-09-30 WO PCT/GB2021/052535 patent/WO2022069894A1/en not_active Ceased
- 2021-09-30 EP EP21816508.2A patent/EP4222147B1/en active Active
- 2021-09-30 CA CA3193947A patent/CA3193947A1/en active Pending
- 2021-09-30 JP JP2023520459A patent/JP7793614B2/ja active Active
- 2021-09-30 ES ES21816508T patent/ES3018732T3/es active Active
- 2021-09-30 US US18/028,192 patent/US20230382930A1/en active Pending
- 2021-09-30 MX MX2023003825A patent/MX2023003825A/es unknown
- 2021-09-30 AU AU2021352146A patent/AU2021352146A1/en active Pending
- 2021-09-30 PL PL21816508.2T patent/PL4222147T3/pl unknown
- 2021-09-30 KR KR1020237014527A patent/KR20230079163A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023543924A5 (https=) | ||
| EP4125896B1 (en) | Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof | |
| US6638530B1 (en) | Benzamide formulation with histone deacetylase inhibitor activity | |
| EP3720431B1 (en) | Fatty acid derivatives for treating non-alcoholic steatohepatitis | |
| JP5698682B2 (ja) | トライアシル−３−ヒドロキシフェニルアデノシン及びその血中脂肪の調節用途 | |
| TW201639571A (zh) | 非酒精性脂肪肝病以及/或脂質營養不良症之治療方法 | |
| AU2006295440A1 (en) | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | |
| CN1711085A (zh) | 含乙酸酰基苯胺衍生物作为活性成分的膀胱活动过度的治疗药物 | |
| JP7793614B2 (ja) | チアジアゾロン誘導体と、それらの糖尿病および関連疾患の治療のためのａｍｐｋアゴニストとしての使用 | |
| KR20170061616A (ko) | 피마살탄의 신규 염 | |
| US12453719B2 (en) | Treatment method using a complex of angiotensin II receptor antagonist metabolite and NEP inhibitor | |
| JP6014623B2 (ja) | 急性心不全の治療のための方法および組成物 | |
| KR20170106485A (ko) | 요산 또는 통풍 질환의 예방 또는 치료 | |
| WO2011141419A1 (en) | Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof | |
| JP2010529113A (ja) | ピラゾロピリミジノン誘導体化合物を含む慢性心不全治療用医薬組成物 | |
| TW201206432A (en) | Association of xanthine oxidase inhibitors and angiotensin II receptor antagonists and use thereof | |
| JP2022541178A (ja) | （ｓ）－３－アミノ－６－メトキシ－ｎ－（３，３，３－トリフルオロ－２－ヒドロキシ－２－メチルプロピル）－５－（トリフルオロメチル）ピコリンアミド製剤 | |
| TWI659739B (zh) | 便秘症之預防或治療藥 | |
| US20260090994A1 (en) | Tablet formulations | |
| CN120988049A (zh) | 一种含氟化合物及其制备方法和应用 | |
| EP3560490B1 (en) | Oral ibuprofen preparation | |
| CN1255110C (zh) | 一种治疗冠心病的中药组合物及其用途 | |
| JP2764287B2 (ja) | 胃炎治療剤 | |
| AU2021405273A1 (en) | Combination therapies comprising oxygen-containing structurally enhanced fatty acids for treatment of non-alcoholic steatohepatitis | |
| JP2022510436A5 (https=) |